- Home
- PED vs UNCY Comparison
PED vs UNCY Comparison
Compare PED & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- UNCY
- Stock Information
- Founded
- PED N/A
- UNCY 2016
- Country
- PED United States
- UNCY United States
- Employees
- PED N/A
- UNCY N/A
- Industry
- PED Oil & Gas Production
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- UNCY Health Care
- Exchange
- PED Nasdaq
- UNCY Nasdaq
- Market Cap
- PED 70.3M
- UNCY 58.7M
- IPO Year
- PED N/A
- UNCY 2021
- Fundamental
- Price
- PED $0.70
- UNCY $0.61
- Analyst Decision
- PED Strong Buy
- UNCY Strong Buy
- Analyst Count
- PED 3
- UNCY 3
- Target Price
- PED $1.83
- UNCY $5.33
- AVG Volume (30 Days)
- PED 56.6K
- UNCY 789.1K
- Earning Date
- PED 05-14-2025
- UNCY 05-12-2025
- Dividend Yield
- PED N/A
- UNCY N/A
- EPS Growth
- PED 125.69
- UNCY N/A
- EPS
- PED 0.02
- UNCY N/A
- Revenue
- PED $35,719,000.00
- UNCY N/A
- Revenue This Year
- PED $26.32
- UNCY N/A
- Revenue Next Year
- PED $2.77
- UNCY N/A
- P/E Ratio
- PED $28.79
- UNCY N/A
- Revenue Growth
- PED 19.19
- UNCY N/A
- 52 Week Low
- PED $0.69
- UNCY $0.20
- 52 Week High
- PED $1.10
- UNCY $1.60
- Technical
- Relative Strength Index (RSI)
- PED 40.25
- UNCY 51.64
- Support Level
- PED $0.69
- UNCY $0.60
- Resistance Level
- PED $0.76
- UNCY $0.69
- Average True Range (ATR)
- PED 0.04
- UNCY 0.05
- MACD
- PED 0.00
- UNCY 0.00
- Stochastic Oscillator
- PED 9.52
- UNCY 52.69
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on the acquisition and development of oil and natural gas assets in modern drilling and completion techniques and technologies have yet to be applied. The company focuses on legacy proved properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin) and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.